Affiliation: World Health Organization
- Global support for new vaccine implementation in middle-income countriesMiloud Kaddar
World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
Vaccine 31:B81-96. 2013..This will require political will, joint planning, and additional modest funding...
- Financial challenges of immunization: a look at GAVIMiloud Kaddar
Department of Immunization, Vaccines and Biologicals, World Health Organization, CH 1211 Geneva 27, Switzerland
Bull World Health Organ 82:697-702. 2004..This article focuses on how GAVI is addressing the challenge of sustaining adequate and reliable funding for immunizations in the poorest countries...
- Are current debt relief initiatives an option for scaling up health financing in beneficiary countries?M Kaddar
Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland
Bull World Health Organ 86:877-83. 2008..There should be careful monitoring of fungibility (i.e. where untraceable funds risk substitution) and additionality (i.e. the extent to which new inputs add to existing inputs at national and international level)...
- The impact of the Global Polio Eradication Initiative on the financing of routine immunization: case studies in Bangladesh, C te d'Ivoire, and MoroccoAnn Levin
Family Health International, Washington, DC 20008, USA
Bull World Health Organ 80:822-8. 2002..The results show that the PEI did not reduce funding for routine immunizations in these countries...
- The economics of vaccination in low- and middle-income countriesJ A Fox-Rushby
Bull World Health Organ 82:640. 2004
- Managing the effect of TRIPS on availability of priority vaccinesJulie Milstien
Center for Vaccine Development, School of Medicine, University of Maryland, Montpellier, France
Bull World Health Organ 84:360-5. 2006..The role of international organizations in defining best practices, dissemination of information, and monitoring TRIPS impact will be crucial to ensuring optimal access to priority new vaccines for the developing world...
- Access to vaccine technologies in developing countries: Brazil and IndiaJulie B Milstien
University of Maryland School of Medicine, 3 bis rue des Coronilles, Résidence Parc de Clementville Bâtiment C, 34070 Montpellier, France
Vaccine 25:7610-9. 2007..A case study on development of a new combination vaccine illustrates these findings...